Diagnostic classifications based on cognitive, CSF, and PET biomarkers across ADNI cohorts: cross-sectional and longitudinal variability
Insight is provided into the observed heterogeneities and their potential contributing factors in Alzheimer’s disease biomarker heterogeneity, which underscore the complexity and variability of Alzheimer’s disease phenotypes and progression and provide a sanguine perspective on current diagnostic frameworks.